If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Elena Verzoni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 20 Similar Profiles
Renal Cell Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences
Castration Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Safety Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World Population

Peverelli, G., Raimondi, A., Ratta, R., Verzoni, E., Bregni, M., Cortesi, E., Cartenì, G., Fornarini, G., Facchini, G., Buti, S., Galli, L., Tucci, M., Prisciandaro, M. & Procopio, G., Jan 1 2019, In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Neoplasm Metastasis
Safety
Brain
Population

Collecting ducts carcinoma: An orphan disease. Literature overview and future perspectives

Pagani, F., Colecchia, M., Sepe, P., Apollonio, G., Claps, M., Verzoni, E., de Braud, F. & Procopio, G., Sep 2019, In : Cancer Treatment Reviews. 79, 101891.

Research output: Contribution to journalReview article

Rare Diseases
Renal Cell Carcinoma
gemcitabine
Survival
Kidney Neoplasms
Open Access
Circulating Neoplastic Cells
Castration
Prostatic Neoplasms
Androgen Receptors
Disease-Free Survival

Do biomarkers play a predictive role for response to novel immunotherapeutic agents in metastatic renal cell carcinoma?

Raimondi, A., Sepe, P., Claps, M., Verzoni, E. & Procopio, G., Nov 2 2019, In : Expert Opinion on Biological Therapy. 19, 11, p. 1107-1110 4 p.

Research output: Contribution to journalEditorial

4 Citations (Scopus)

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: The Italian expanded access program

Verzoni, E., Cartenì, G., Cortesi, E., Giannarelli, D., De Giglio, A., Sabbatini, R., Buti, S., Rossetti, S., Cognetti, F., Rastelli, F., Sobrero, A., Turci, D., Sternberg, C. N., Porta, C., Cappuzzo, F., Tortora, G., Tassinari, D., Panni, S., Pazzola, A., Surico, G. & 3 others, Raimondi, A., De Giorgi, U. & Procopio, G., Apr 3 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 99.

Research output: Contribution to journalArticle

Open Access
Renal Cell Carcinoma
Drug-Related Side Effects and Adverse Reactions
Safety
Survival
Logistic Models